Susan K. Bohnenkamp, an oncology clinical nurse specialist, is recognized for her compassionate and expert care, going above and beyond to support her patients through their cancer journey.

From James Van Der Beek spreading awareness about colorectal cancer at a younger age to Gerry Connolly’s recent esophageal ...

After cancer treatment, I wanted to go right back to living my life normally, but a fellow CURE blogger’s post reminded me ...

The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...

My daughter's diagnosis of a rare and aggressive brain tumor at 3 years old made me strongly consider whether or not to have her treated with radiation.

Graft-versus-host disease prophylaxis using posttransplant cyclophosphamide remains a valid option for patients with ...

Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...

In this on-demand webinar series, CURE partnered with City of Hope to discuss effective communication when making treatment ...

Induction chemotherapy shows significant improvements for survival in patients with locally advanced cervical cancer.

CURE partnered with City of Hope for a webinar to discuss focusing on quality of life when talking with care teams during ...

The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.

The CAR-T cell therapy Carvykti has been shown to be effective among patients outside the confines of a clinical trial.